
Valerie Rodriguez-garcia
Examiner (ID: 32, Phone: (571)270-5865 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1621, 1759, 1626, 1622 |
| Total Applications | 1118 |
| Issued Applications | 736 |
| Pending Applications | 90 |
| Abandoned Applications | 322 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13357111
[patent_doc_number] => 20180230095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => METHOD FOR PRODUCING PYRROLE DERIVATIVE, AND INTERMEDIATE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/950973
[patent_app_country] => US
[patent_app_date] => 2018-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15950973
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/950973 | Method for producing pyrrole derivative, and intermediate thereof | Apr 10, 2018 | Issued |
Array
(
[id] => 17007004
[patent_doc_number] => 20210238165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => HETEROARYL RHEB INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/604208
[patent_app_country] => US
[patent_app_date] => 2018-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604208
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/604208 | Heteroaryl Rheb inhibitors and uses thereof | Apr 8, 2018 | Issued |
Array
(
[id] => 13492807
[patent_doc_number] => 20180297946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/947049
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7051
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947049
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/947049 | POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF | Apr 5, 2018 | Abandoned |
Array
(
[id] => 13492805
[patent_doc_number] => 20180297945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/947044
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7052
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15947044
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/947044 | POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF | Apr 5, 2018 | Abandoned |
Array
(
[id] => 15768773
[patent_doc_number] => 20200115404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => CD73 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/498338
[patent_app_country] => US
[patent_app_date] => 2018-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51712
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498338 | CD73 INHIBITORS AND USES THEREOF | Mar 28, 2018 | Abandoned |
Array
(
[id] => 15435171
[patent_doc_number] => 20200031769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => NOVEL POLYMORPHS OF (5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDE HYDROCHLORIDE
[patent_app_type] => utility
[patent_app_number] => 16/493492
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8558
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493492
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493492 | NOVEL POLYMORPHS OF (5-[3-(3-HYDROXYPHENOXY)AZETIDIN-1-YL]-5-METHYL-2,2-DIPHENYLHEXANAMIDE HYDROCHLORIDE | Mar 14, 2018 | Abandoned |
Array
(
[id] => 14519011
[patent_doc_number] => 10336752
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => TYK2 inhibitors, uses, and methods for production thereof
[patent_app_type] => utility
[patent_app_number] => 15/914074
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25643
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15914074
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/914074 | TYK2 inhibitors, uses, and methods for production thereof | Mar 6, 2018 | Issued |
Array
(
[id] => 14699935
[patent_doc_number] => 10377700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Process for the recovery of a boronic acid
[patent_app_type] => utility
[patent_app_number] => 15/912772
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10510
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15912772
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/912772 | Process for the recovery of a boronic acid | Mar 5, 2018 | Issued |
Array
(
[id] => 16236747
[patent_doc_number] => 20200253981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => USES OF PYRIMIDOPYRIMIDINONES AS SIK INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/489462
[patent_app_country] => US
[patent_app_date] => 2018-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -156
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489462
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489462 | Uses of pyrimidopyrimidinones as SIK inhibitors | Feb 27, 2018 | Issued |
Array
(
[id] => 14609653
[patent_doc_number] => 10357504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Thromboxane receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 15/901503
[patent_app_country] => US
[patent_app_date] => 2018-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 29
[patent_no_of_words] => 12446
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15901503
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/901503 | Thromboxane receptor antagonists | Feb 20, 2018 | Issued |
Array
(
[id] => 14746565
[patent_doc_number] => 20190256456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS
[patent_app_type] => utility
[patent_app_number] => 15/899843
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15899843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/899843 | Alcohol derivatives of carboxamides as Kv7 potassium channel openers | Feb 19, 2018 | Issued |
Array
(
[id] => 13856185
[patent_doc_number] => 10189801
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-01-29
[patent_title] => Method for synthesizing tetrahydroisoquinoline thiazolidine
[patent_app_type] => utility
[patent_app_number] => 15/900117
[patent_app_country] => US
[patent_app_date] => 2018-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2946
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15900117
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/900117 | Method for synthesizing tetrahydroisoquinoline thiazolidine | Feb 19, 2018 | Issued |
Array
(
[id] => 13427975
[patent_doc_number] => 20180265530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => CRYSTALLINE FORMS OF TENOFOVIR ALAFENAMIDE
[patent_app_type] => utility
[patent_app_number] => 15/882784
[patent_app_country] => US
[patent_app_date] => 2018-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28368
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -74
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15882784
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/882784 | Crystalline forms of tenofovir alafenamide | Jan 28, 2018 | Issued |
Array
(
[id] => 13383487
[patent_doc_number] => 20180243285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => 3-(1-OXO-4-((4-((3-OXOMORPHOLINO)METHYL)BENZYL)OXY)ISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE AND ISOTOPOLOGUES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/881501
[patent_app_country] => US
[patent_app_date] => 2018-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15881501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/881501 | 3-(1-oxo-4-((4-((3-oxomorpholino)methyl)benzyl)oxy)isoindolin-2-yl)piperidine-2,6-dione and isotopologues thereof | Jan 25, 2018 | Issued |
Array
(
[id] => 13479029
[patent_doc_number] => 20180291057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => OXYSTEROLS FOR USE IN THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY VIRUSES
[patent_app_type] => utility
[patent_app_number] => 15/877831
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9133
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15877831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/877831 | OXYSTEROLS FOR USE IN THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY VIRUSES | Jan 22, 2018 | Abandoned |
Array
(
[id] => 13314127
[patent_doc_number] => 20180208600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/872571
[patent_app_country] => US
[patent_app_date] => 2018-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79946
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15872571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/872571 | BICYCLIC HETEROCYCLIC DERIVATIVES AS MNK1 AND MNK2 MODULATORS AND USES THEREOF | Jan 15, 2018 | Abandoned |
Array
(
[id] => 14003175
[patent_doc_number] => 10220015
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Fumigillol compounds and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 15/869368
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 10236
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15869368
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/869368 | Fumigillol compounds and methods of making and using same | Jan 11, 2018 | Issued |
Array
(
[id] => 17421204
[patent_doc_number] => 11254645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Method for preparing tolimidone on large scale
[patent_app_type] => utility
[patent_app_number] => 16/960796
[patent_app_country] => US
[patent_app_date] => 2018-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 4003
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960796
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960796 | Method for preparing tolimidone on large scale | Jan 10, 2018 | Issued |
Array
(
[id] => 15666309
[patent_doc_number] => 10597372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Simplified structural mimetics of AIPS as quorum sensing inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/850300
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 35
[patent_no_of_words] => 21645
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15850300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/850300 | Simplified structural mimetics of AIPS as quorum sensing inhibitors | Dec 20, 2017 | Issued |
Array
(
[id] => 15483175
[patent_doc_number] => 10556920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Phosphorus-containing heterocycles and a method for making and using
[patent_app_type] => utility
[patent_app_number] => 15/850388
[patent_app_country] => US
[patent_app_date] => 2017-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9710
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15850388
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/850388 | Phosphorus-containing heterocycles and a method for making and using | Dec 20, 2017 | Issued |